Literature DB >> 11435568

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

N Kaludov1, K E Brown, R W Walters, J Zabner, J A Chiorini.   

Abstract

Adeno-associated virus serotype 4 (AAV4) and AAV5 have different tropisms compared to AAV2 and to each other. We recently reported that alpha 2--3 sialic acid is required for AAV5 binding and transduction. In this study, we characterized AAV4 binding and transduction and found it also binds sialic acid, but the specificity is significantly different from AAV5. AAV4 can hemagglutinate red blood cells from several species, whereas AAV5 hemagglutinates only rhesus monkey red blood cells. Treatment of red blood cells with trypsin inhibited hemagglutination for both AAV4 and AAV5, suggesting that the agglutinin is a protein. Treatment of Cos and red blood cells with neuraminidases also indicated that AAV4 bound alpha 2--3 sialic acid. However, resialylation experiments with neuraminidase-treated red blood cells demonstrated that AAV4 binding required alpha 2--3 O-linked sialic acid, whereas AAV5 required N-linked sialic acid. Similarly, resialylation of sialic acid-deficient CHO cells supported this same conclusion. The difference in linkage specificity for AAV4 and AAV5 was confirmed by binding and transduction experiments with cells incubated with either N-linked or O-linked inhibitors of glycosylation. Furthermore, AAV4 transduction was only blocked with soluble alpha 2-3 sialic acid, whereas AAV5 could be blocked with either alpha 2--3 or alpha 2-6 sialic acid. These results suggest that AAV4 and AAV5 require different sialic acid-containing glycoproteins for binding and transduction of target cells and they further explain the different tropism of AAV4 and AAV5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435568      PMCID: PMC114416          DOI: 10.1128/JVI.75.15.6884-6893.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles.

Authors:  S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 2.  Diversity in the sialic acids.

Authors:  A Varki
Journal:  Glycobiology       Date:  1992-02       Impact factor: 4.313

3.  Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins.

Authors:  J C Paulson; G N Rogers
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

5.  Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes.

Authors:  L D Cahan; J C Paulson
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

6.  Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid.

Authors:  D B Tresnan; L Southard; W Weichert; J Y Sgro; C R Parrish
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

7.  Characterization of the DNA of a defective human parvovirus isolated from a genital site.

Authors:  U Bantel-Schaal; H zur Hausen
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

8.  Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2----3 linkages.

Authors:  L L Hoyer; P Roggentin; R Schauer; E R Vimr
Journal:  J Biochem       Date:  1991-09       Impact factor: 3.387

9.  Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding.

Authors:  D P Barbis; S F Chang; C R Parrish
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

10.  The release of N-acetyl- and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases.

Authors:  A P Corfield; R W Veh; M Wember; J C Michalski; R Schauer
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

View more
  162 in total

1.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

Review 2.  Pathways of cell infection by parvoviruses and adeno-associated viruses.

Authors:  Maija Vihinen-Ranta; Sanna Suikkanen; Colin R Parrish
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Authors:  Joseph E Rabinowitz; Dawn E Bowles; Susan M Faust; Julie G Ledford; Scott E Cunningham; R Jude Samulski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.

Authors:  Carole E Harbison; Wendy S Weichert; Brittney L Gurda; John A Chiorini; Mavis Agbandje-McKenna; Colin R Parrish
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

Review 5.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

6.  Polarized AAVR expression determines infectivity by AAV gene therapy vectors.

Authors:  Bradley A Hamilton; Xiaopeng Li; Alejandro A Pezzulo; Mahmoud H Abou Alaiwa; Joseph Zabner
Journal:  Gene Ther       Date:  2019-04-08       Impact factor: 5.250

7.  Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.

Authors:  Johnna M Frierson; Andrea J Pruijssers; Jennifer L Konopka; Dirk M Reiter; Ty W Abel; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Recombinant adeno-associated virus vectors in the treatment of rare diseases.

Authors:  Eric Hastie; R Jude Samulski
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-15       Impact factor: 0.694

9.  Role of Tetra Amino Acid Motif Properties on the Function of Protease-Activatable Viral Vectors.

Authors:  T M Robinson; J Judd; M L Ho; J Suh
Journal:  ACS Biomater Sci Eng       Date:  2016-09-28

10.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.